Personalized bevacizumab dosing in metastatic colorectal cancer: Statistical considerations for a phase III randomized trial
- 6 June 2025
- journal article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 57 (9) , 1874
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit: